Laurence A. Turka - Net Worth and Insider Trading
Laurence A. Turka Net Worth
The estimated net worth of Laurence A. Turka is at least $1,048 dollars as of 2024-05-02. Laurence A. Turka is the Chief Scientific Officer of Rubius Therapeutics Inc and owns about 18,391 shares of Rubius Therapeutics Inc (RUBY) stock worth over $1,048. Details can be seen in Laurence A. Turka's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Laurence A. Turka has not made any transactions after 2023-01-31 and currently still holds the listed stock(s).
Transaction Summary of Laurence A. Turka
Laurence A. Turka Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Laurence A. Turka owns 1 companies in total, including Rubius Therapeutics Inc (RUBY) .
Click here to see the complete history of Laurence A. Turka’s form 4 insider trades.
Insider Ownership Summary of Laurence A. Turka
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RUBY | Rubius Therapeutics Inc | 2023-01-31 | Chief Scientific Officer |
Laurence A. Turka Latest Holdings Summary
Laurence A. Turka currently owns a total of 1 stock. Laurence A. Turka owns 18,391 shares of Rubius Therapeutics Inc (RUBY) as of January 31, 2023, with a value of $1,048.
Latest Holdings of Laurence A. Turka
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RUBY | Rubius Therapeutics Inc | 2023-01-31 | 18,391 | 0.06 | 1,048 |
Holding Weightings of Laurence A. Turka
Laurence A. Turka Form 4 Trading Tracker
According to the SEC Form 4 filings, Laurence A. Turka has made a total of 2 transactions in Rubius Therapeutics Inc (RUBY) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Rubius Therapeutics Inc is the sale of 2,593 shares on January 31, 2023, which brought Laurence A. Turka around $622.
Insider Trading History of Laurence A. Turka
- 1
Laurence A. Turka Trading Performance
Laurence A. Turka Ownership Network
Laurence A. Turka Owned Company Details
What does Rubius Therapeutics Inc do?
Who are the key executives at Rubius Therapeutics Inc?
Laurence A. Turka is the Chief Scientific Officer of Rubius Therapeutics Inc. Other key executives at Rubius Therapeutics Inc include CEO and President Dannielle Appelhans , director & Chief Executive Officer Pablo J Cagnoni , and CLO & Corp. Secretary Maiken Keson-brookes .
Rubius Therapeutics Inc (RUBY) Insider Trades Summary
Over the past 18 months, Laurence A. Turka made 1 insider transaction in Rubius Therapeutics Inc (RUBY) with a net sale of 2,593. Other recent insider transactions involving Rubius Therapeutics Inc (RUBY) include a net sale of 15,688 shares made by Pablo J Cagnoni , a net sale of 14,263 shares made by Dannielle Appelhans ,
In summary, during the past 3 months, insiders sold 0 shares of Rubius Therapeutics Inc (RUBY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 32,544 shares of Rubius Therapeutics Inc (RUBY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 32,544 shares.
Rubius Therapeutics Inc (RUBY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rubius Therapeutics Inc Insider Transactions
Laurence A. Turka Mailing Address
Above is the net worth, insider trading, and ownership report for Laurence A. Turka. You might contact Laurence A. Turka via mailing address: C/o Rubius Therapeutics, Inc., 399 Binney St., Suite 300, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
